date:Jun 06, 2014
results. GLG subsequently submitted that dossier to the FDA for review, resulting in the FDA's letter of no objection.
The latest GRAS designations further GLG's commitment to maintaining the highest quality standards for its products. To date, it has received five GRAS letters of no objection covering an array of high-purity stevia products, with a sixth GRAS determination pending FDA review (for high-purity rebaudioside M) and two other GRAS projects currently underway (for high-purity rebaud